We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Fusion Antibodies Plc | LSE:FAB | London | Ordinary Share | GB00BDQZGK16 | ORD 4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.05 | -1.32% | 3.75 | 3.70 | 3.80 | 3.80 | 3.75 | 3.80 | 187,413 | 08:00:57 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 2.9M | -2.6M | -0.0437 | -0.86 | 2.23M |
TIDMFAB
Fusion Antibodies PLC
23 April 2018
23 April 2018
Fusion Antibodies plc
("Fusion" or the "Company")
Investor presentation
Fusion Antibodies (AIM: FAB), a contract research organization providing a range of antibody engineering services for the development of antibodies for both therapeutic drug and diagnostic applications, announces that it will hold a presentation for investors on Wednesday, 2 May 2018.
The briefing by Paul Kerr, CEO of Fusion will take place at Copper Bar, Balls Brothers, 6 Adams Court, Old Broad Street, EC2N 1DX from 4.30pm for a 4.45pm start and will be followed by drinks and networking. If you would like to register to attend, please contact Walbrook PR on 020 7933 8780 or email fusion@walbrookpr.com.
Enquiries:
Fusion Antibodies plc www.fusionantibodies.com Dr Paul Kerr, Chief Executive Officer Via Walbrook PR James Fair, Chief Financial Officer Walbrook PR Tel: +44 (0)20 7933 8780 or fusion@walbrookpr.com Paul McManus Mob: +44 (0)7980 541 893 Anna Dunphy Mob: +44 (0)7876 741 001
This information is provided by RNS
The company news service from the London Stock Exchange
END
NRAPGUMUCUPRUBW
(END) Dow Jones Newswires
April 23, 2018 05:09 ET (09:09 GMT)
1 Year Fusion Antibodies Chart |
1 Month Fusion Antibodies Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions